Journal Article

Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643

Mari Iida, Colleen H. Anna, Jennifer Hartis, Maribel Bruno, Barbara Wetmore, Joshua R. Dubin, Stella Sieber, Lee Bennett, Michael L. Cunningham, Richard S. Paules, Kenneth B. Tomer, Christopher D. Houle, Alex B. Merrick, Robert C. Sills and Theodora R. Devereux

in Carcinogenesis

Volume 24, issue 4, pages 757-770
Published in print April 2003 | ISSN: 0143-3334
Published online April 2003 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgg011
Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

We hypothesized that the mouse liver tumor response to non-genotoxic carcinogens would involve some common early gene and protein expression changes that could ultimately be used to predict chemical hepatocarcinogenesis. In order to identify a panel of genes to test, we analyzed global differences in gene and protein expression in livers from B6C3F1 mice following dietary treatment with two rodent carcinogens, the benzodiazepine anti-anxiety drug oxazepam (2500 p.p.m.) and the hypolipidemic agent Wyeth (Wy)-14,643 (500 p.p.m.) compared with livers from untreated mice. Male mice were exposed for 2 weeks and 1, 3 or 6 months to oxazepam or Wy-14,643 in an age-matched study design. By histopathological evaluation, no liver preneoplastic foci or tumors were detected at 6 months in treated or control groups. By cDNA microarray analysis [NIEHS Mouse Chip (8700 genes); n = 3 individual livers/group, four hybridizations/sample], expression of 36 genes or 220 genes were changed relative to control livers following 6 months of oxazepam or Wy-14,643 treatment, respectively. To obtain a more comprehensive picture of gene/protein expression changes, we also conducted a proteomics study by 2D-gel electrophoresis followed by matrix assisted laser desorption/ionization-mass spectrometry on cytoplasmic, nuclear, and microsomal subcellular fractions of the same liver samples utilized for the cDNA microarray analysis. Real-time PCR, western blot analysis and immunohistochemistry were utilized for validation and to expand the results to other time points. Cyp2b20, growth arrest- and damage-inducible gene β (Gadd45β), tumor necrosis factor α-induced protein 2 and insulin-like growth factor binding protein 1 (Igfbp5) genes and proteins were upregulated by oxazepam, and Cyp2b20, Cyclin D1, proliferating cell nuclear antigen, Igfbp5, Gadd45β and cell death-inducing DNA fragmentation factor α subunit-like effector A exhibited higher expression after Wy-14,643 treatment. Most of these genes/proteins were also deregulated at 2 weeks. There appeared to be more distinct than common changes in the expression of carcinogenesis-related genes/proteins between the two compounds, suggesting that the major carcinogenic pathways are different for these compounds and may be distinct for different chemical classes.

Keywords: AFP, α-fetoprotein; Cide-A, cell death-inducing DNA fragmentation factor α subunit-like effector A; EST, expressed sequence tag; Gadd45β, growth arrest- and DNA damage-inducible gene β; HCC, hepatocellular carcinoma; Igf-I, insulin-like growth factor I; Igfbp1, insulin-like growth factor binding protein 1; Maf, v-musculoaponeurotic fibrosarcoma oncogene family, protein F; MALDI, matrix assisted laser desorption/ionization; Map3k7, mitogen activated protein kinase kinase kinase 7; MS, mass spectrometry; PP, peroxisome proliferators; PPARα, peroxisome proliferator activated receptor α; PCNA, proliferating cell nuclear antigen; Tff-1, Trefoil factor 1; Tnfaip2, tumor necrosis factor α-induced protein 2; Wy-14,643, Wyeth-14,643.

Journal Article.  10223 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.